Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIZATRIPTAN vs ROFLUMILAST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIZATRIPTAN vs ROFLUMILAST: Safety Overview

Metric RIZATRIPTAN ROFLUMILAST
Total FAERS Reports 2,896 2,700
Deaths Reported 68 645
Death Rate 2.3% 23.9%
Hospitalizations 479 625
Average Patient Age 44.6 yrs 68.8 yrs
% Female Patients 77.2% 56.3%
FDA Approval Date Apr 14, 2023 Apr 17, 2023
Manufacturer Panacea Biotec Limited Aurobindo Pharma Limited
Route ORAL ORAL
Marketing Status Discontinued Prescription